European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS

Assessing, preserving and restoring man-microbes symbiosis

Descrizione del progetto

Migliorare il microbioma intestinale umano

Il microbioma umano ospita una comunità di microrganismi. La ricerca ha dimostrato che un microbioma intestinale diversificato è un microbioma più sano e dà un contributo vitale alla nostra salute. Circa un terzo della popolazione soffre di uno squilibrio microbico intestinale (disbiosi), uno stato caratterizzato da interazioni alterate tra i microbi simbiotici e il loro ospite. Ciò potrebbe portare a malattie incurabili mediate dal sistema immunitario, per le quali le attuali terapie si limitano ad alleviare i sintomi. Il progetto Homo.symbiosus finanziato dall’UE, prevede di sviluppare nuovi approcci terapeutici basati sull’ecologia intestinale per ripristinare la simbiosi uomo-microbo.

Obiettivo

The microbiomics revolution has favoured the recognition of the gut as a true organ and the importance of man-microbes symbiosis in health and disease. Derived from a long co-evolution the latter has been challenged by numerous environmental triggers, modern lifestyles, changes in birth modalities, nutritional transition and therapeutic attitudes. A large fraction of the human population has tentatively entered a man-microbes dysbiotic state characterized by altered interactions between microbiome and host features with auto-aggravating crosstalk signals. The result is increased incidence of incurable immune-mediated diseases of modern societies that affect a third the human population on earth today and for which current therapeutics only address symptoms alleviation, rather than considering man as a holobiont.
In this context and its resulting threat for the human species, I will carry out a project geared to open a new era of individualized preventive care and novel gut ecology-based therapeutic approaches. The project will assemble insights and contributions from theoretical to experimental ecology, quantitative and functional microbiomics, preclinical work, cohort studies and clinical trials, so as to:
• Validate the concept of critical transition and alternative stable state as it applies to a shift from man-microbes symbiosis to disease-prone man-microbes dysbiosis
• Assess the potential of diet alone to promote such a shift
• Model the symbiosis-to-dysbiosis transitions and derive predictors of tipping points
• Propose counter-measures that may allow to break vicious circles and restore a balanced, health-prone, man-microbes symbiosis by concomitantly acting upon microbiome and host features
• Validate strategies to reinforce ecological robustness and restore man-microbes symbiosis
Based on a paradigm shift, the proposed work will set the grounds for future personalized preventive nutrition and clinical management considering man as a true holobiont.

Meccanismo di finanziamento

ERC-ADG - Advanced Grant

Istituzione ospitante

INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT
Contribution nette de l'UE
€ 2 291 014,00
Indirizzo
147 RUE DE L'UNIVERSITE
75007 Paris
Francia

Mostra sulla mappa

Regione
Ile-de-France Ile-de-France Paris
Tipo di attività
Research Organisations
Collegamenti
Costo totale
€ 2 491 014,00

Beneficiari (2)